There are no files associated with this item.
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.citation.endPage | 839 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 829 | - |
dc.citation.title | DIABETES | - |
dc.citation.volume | 65 | - |
dc.contributor.author | Choi, Sun-sil | - |
dc.contributor.author | Kim, Eun-Sun | - |
dc.contributor.author | Jung, Ji-Eun | - |
dc.contributor.author | Marciano, David P. | - |
dc.contributor.author | Jo, Ala | - |
dc.contributor.author | Koo, Ja Young | - |
dc.contributor.author | Choi, Soo Youn | - |
dc.contributor.author | Yang, Yong Ryoul | - |
dc.contributor.author | Jang, Hyun-Jun | - |
dc.contributor.author | Kim, Eung-Kyun | - |
dc.contributor.author | Park, Jiyoung | - |
dc.contributor.author | Kwon, H. Moo | - |
dc.contributor.author | Lee, In Hee | - |
dc.contributor.author | Park, Seung Bum | - |
dc.contributor.author | Myung, Kyungjae | - |
dc.contributor.author | Suh, Pann-Ghill | - |
dc.contributor.author | Griffin, Patrick R. | - |
dc.contributor.author | Choi, Jang Hyun | - |
dc.date.accessioned | 2023-12-22T00:06:30Z | - |
dc.date.available | 2023-12-22T00:06:30Z | - |
dc.date.created | 2016-04-04 | - |
dc.date.issued | 2016-04 | - |
dc.description.abstract | Blocking phosphorylation of peroxisome proliferator-activated receptor (PPAR)γ at Ser273 is one of the key mechanisms for antidiabetes drugs to target PPARγ. Using high-throughput phosphorylation screening, we here describe that Gleevec blocks cyclin-dependent kinase 5-mediated PPARγ phosphorylation devoid of classical agonism as a PPARγ antagonist ligand. In high fat-fed mice, Gleevec improved insulin sensitivity without causing severe side effects associated with other PPARγ-targeting drugs. Furthermore, Gleevec reduces lipogenic and gluconeogenic gene expression in liver and ameliorates inflammation in adipose tissues. Interestingly, Gleevec increases browning of white adipose tissue and energy expenditure. Taken together, the results indicate that Gleevec exhibits greater beneficial effects on both glucose/lipid metabolism and energy homeostasis by blocking PPARγ phosphorylation. These data illustrate that Gleevec could be a novel therapeutic agent for use in insulin resistance and type 2 diabetes. | - |
dc.identifier.bibliographicCitation | DIABETES, v.65, no.4, pp.829 - 839 | - |
dc.identifier.doi | 10.2337/db15-1382 | - |
dc.identifier.issn | 0012-1797 | - |
dc.identifier.scopusid | 2-s2.0-84962132633 | - |
dc.identifier.uri | https://scholarworks.unist.ac.kr/handle/201301/18929 | - |
dc.identifier.url | http://diabetes.diabetesjournals.org/content/65/4/829.abstract | - |
dc.identifier.wosid | 000372859200003 | - |
dc.language | 영어 | - |
dc.publisher | AMER DIABETES ASSOC | - |
dc.title | PPAR gamma Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue | - |
dc.type | Article | - |
dc.description.isOpenAccess | FALSE | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | ACTIVATED-RECEPTOR-GAMMA | - |
dc.subject.keywordPlus | IMATINIB-MESYLATE GLEEVEC | - |
dc.subject.keywordPlus | BEIGE FAT | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | LIGAND | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | THIAZOLIDINEDIONE | - |
dc.subject.keywordPlus | INFLAMMATION | - |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Tel : 052-217-1404 / Email : scholarworks@unist.ac.kr
Copyright (c) 2023 by UNIST LIBRARY. All rights reserved.
ScholarWorks@UNIST was established as an OAK Project for the National Library of Korea.